NCT01144247已完成1 期
A Phase I Clinical Trial Evaluating Cellular Immunotherapy With Intratumoral Alloreactive Cytotoxic T Lymphocytes and Interleukin-2 for the Treatment of Recurrent Malignant Gliomas or Meningiomas
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Number of patients with adverse events as a measure of safety and tolerability
研究概览
简要总结
The purpose of this research study to determine if treating recurrent malignant gliomas with another person's (donor) immune system cells known as aCTL cells, will be safe. This study will also try to determine if persons who receive aCTL's are more or less likely to survive their brain tumor than persons who had similar tumors in the past. Approximately 15 patients will be enrolled at UCLA.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
alloreactive CTL arm
Experimental
干预措施: alloreactive CTL (Drug)
结局指标
主要结局
Number of patients with adverse events as a measure of safety and tolerability
时间窗: 5 years
次要结局
- Maximum tolerated dose(3 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)CNS Germ Cell TumorNCT01270724Nationwide Children's Hospital10
已完成
1 期
Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in GlioblastomaGlioblastomaBrain TumorNCT00846456Oslo University Hospital20
进行中（未招募）
1 期
A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive GlioblastomaBrain CancerNCT02852655Dana-Farber Cancer Institute60
Unknown
2 期
A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced MelanomaMelanomaNCT00746746Ochsner Health System30
已完成
1 期
Immunotherapy for Patients With Brain Stem Glioma and GlioblastomaGlioblastomaBrain Stem GliomaNCT00576641Cedars-Sinai Medical Center22